Method for treating ulcerative colitis
AssigneeSalix Pharmaceuticals, Inc.
InventorsWilliam P. Forbes, Enoch Bortey, Craig Paterson, Pam Golden
Life of this patent
Estimating the term…
Abstract
Provided herein are methods of treating and inducing ulcerative colitis in a subject. Also provided are methods of treating subjects with mild to moderate active ulcerative colitis, including ulcerative proctitis and proctosigmoiditis. Also provided are methods of administering budesonide to a subject to treat ulcerative colitis, including ulcerative proctitis and proctosigmoiditis.
Claims30
A method of treating or inducing remission of ulcerative colitis (UC) in a subject, comprising administering a pharmaceutical foam composition comprising budesonide to the subject, said method comprising administering to the subject 2 mg of budesonide BID (twice daily) for two weeks followed by 2 mg of budesonide QD (once daily) for four weeks.
A method of treating or inducing remission of ulcerative colitis (UC) in a subject comprising rectally administering a pharmaceutical foam composition comprising budesonide to the subject, said method comprising administering to the subject 2 mg of budesonide BID (twice daily) for two weeks followed by 2 mg of budesonide QD (once daily) for four weeks, whereby said method increases the therapeutic effect of budesonide on ulcerative colitis in a subject despite decreased systemic concentration of budesonide.
Dependencies are inferred from the claim text.